Treatment with antrodan only (20 mg/kg and 40 mg/kg), but not cisplatin only, significantly (p < 0.05) reduced the expression of p-p38 by 13% and 22%, respectively, in comparison with the tumor control group. Here, MAPK1 is linked to neoplasm.